期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

C反应蛋白与慢性阻塞性肺疾病 被引量：8

C-reactive protein and chronic obstructive pulmonary disease
原文传递
导出
摘要 C反应蛋白是在机体炎症、感染或组织损伤时，由一种肝细胞合成释放的急性时相反应蛋白。在众多慢性阻塞性肺疾病患者血清中水平增加的炎症因子中，C反应蛋白是研究最多的一种。本文重点针对C反应蛋白在慢性阻塞性肺疾病中的作用方面的进展进行阐述。 C-reactive protein is an acute phase reactant secreted by the liver in response to inflammation,infection,or tissue damage. C-reactive protein is the best studied of these inflammatory markers,which appear to be increase in the serum of COPD patients. Here the review focuses on the recent development in the significance of C-reactive protein to COPD.
作者 徐玮涵 王浩彦
机构地区 首都医科大学附属北京友谊医院呼吸内科
出处 《国际呼吸杂志》 2012年第16期1263-1267,共5页 International Journal of Respiration
关键词 C反应蛋白 慢性阻塞性肺疾病 炎症因子 C reactive protein Chronic obstructive pulmonary disease Inflammatory marker
分类号 R563.9 [医药卫生—呼吸系统]
  • 相关文献

参考文献28

  • 1Cornier MA, Dabelea D, Hernandez TL,et al. The metabolic syndrome. Endocr Rev, 2008,29 : 777-822.
  • 2中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊疗指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(8):17-18.
  • 3Luft FC. More reactive and less reactive C-reactive protein. J Mol Med (Berl) ,2005,83:411-412.
  • 4梁克山,谭兰.C反应蛋白与动脉粥样硬化性疾病[J].山东医学高等专科学校学报,2006,28(2):135-139. 被引量：2
  • 5王前,郑磊,曾方银.超敏C-反应蛋白的研究现状及临床应用[J].中华检验医学杂志,2004,27(8):542-544. 被引量：193
  • 6Roberts WL, Scbwarz EI., Ayanian S, et aI. Performance characteristics of a point of care C reactive protein assay. Clin Chim Acta, 2001,314:255-259.
  • 7Almirall J, Boliloar I, Toran P, et al. Contribution of C reactive protein to the diagnosis and assessment of severity of community acquired pneumonia. Chest, 2004, 125: 1335- 1342.
  • 8Dahl M, Vestbo J, Zacho J, et al. C reactive protein and chronic obstructive pulmonary disease : a Mendelian randomisation approach. Thorax, 2011,66 :197-204.
  • 9van Durme YM, Verhamme KM, Aarnoudse AJ, et al. C reactive protein levels, hapIotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2009,179:375-382.
  • 10de Torres JP, Pinto-Plata V, Casanova C, et al. C reactive protein levels and survival in patients with moderate to very severe COPD. Chest,2008,133 : 1336-1343.

二级参考文献29

  • 1[1]Zwaka TP,Hombach V,Torzewski J.C-reactive protein mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis[J].Circulation,2001,103(9):1194-1197.
  • 2[2]Yeh ET,Anderson HV,Pasceri V,et al.C-reactive protein linking inflammation to cardiovascular complications[J].Circulation,2001,104(9):974-975.
  • 3[3]Whitehead AS,Bruns GA,Markham AF,et al.Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1[J].Science,1983,221(4605):69-71.
  • 4[4]Ridker PM,Stampfer MJ,Rifai N.Novel risk factors for systemic atherosclerosis:a comparison of C-reactive protein,fibrinogen,homocysteine lipoprotein(a),and standard cholesterol screening predictors of peripheral arterial disease[J].JAMA,2001,285(19):2481-2485.
  • 5[5]Shrive AK,Cheetham GM,Holden D,et al.Three dimensional structure of human C-reactive protein[J].Nature Struct Biol,1996,3(4):346-354.
  • 6[6]Roberts WL,Moulton L,Law TC,et al.Evaluation of nine automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications.Part 2[J].Clin Chem,2001,47(3):418-425.
  • 7[7]Ridker PM,Rifai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347(20):1557-1565.
  • 8[8]Rifai N,Ridker PM.Population distributions of C-reactive protein apparently healthy men and women in the United States:implication for clinical interpretation[J].Clin Chem,2003,49(4):666-669.
  • 9[9]Verma S,Wang CH,Li SH,et al.A self-fulfilling prophecy:C-reactive protein attenuates nitric oxide production and inhibits angiogenesis[J].Circulation,2002,106(8):913-919.
  • 10[10]Verma S,Li SH,Badiwala MV,et al.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein[J].Circulation,2002,105(16):1890-1896.

共引文献202

同被引文献88

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量：11
  • 2慢性阻塞性肺疾病急性加重患者机械通气指南（2007）[J].中华急诊医学杂志,2007,16(4):350-357. 被引量：244
  • 3周仲瑛.中医内科学[M].北京:中国中医药出版社,2007:297
  • 4Sasaki K, Fujita I, Hamasaki Y, et al. Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers [ J ]. J Infect Chemother, 2002, 8 (1): 76-80.
  • 5ZHU J, Quyyumi AA, Norman JE, et al. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels [J]. J Am Coil Cardiol, 1999, 34 (6): 1738-1743.
  • 6Smith RP, Lipworth BJ. C-reactive protein in simple community- acquired pnenmonia[J].Chest, 1995, 107 (4): 1028-1031.
  • 7Stockley RA, O'brien C, Pye A, et al. Relationship of sputum color to Nature and outpatient management of acute exacerbations of COPD [J].Chest, 2000, 117 (6): 1638-1645.
  • 8Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients[J]. Clin Microbiol Infect, 2005, 11 (2): 101-108.
  • 9Cals JW,Schot MJ,de Jong SA,et al.Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections:a randomized controlled trial[J].Ann Fam Med,2010,8(2):124-133.
  • 10GOLD Executive Committee.Global Stratagy for the diagnisis,management,and prevention of COPD[EB/OL].[2015-07-01].http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Sept2.pdf.

引证文献8

二级引证文献165

国际呼吸杂志
2012年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部